Competitors of Sanofi India Ltd in the Pharmaceuticals Sector
| Stock Name | Market Cap | Current Price | High / Low | Stock P/E | Book Value | Dividend Yield | ROCE | ROE | Face Value |
|---|---|---|---|---|---|---|---|---|---|
| Gujarat Themis Biosyn Ltd | 3,205 Cr. | 294 | 390/108 | 60.8 | 20.5 | 0.23 % | 45.0 % | 33.8 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 61.0 Cr. | 82.2 | 94.9/25.8 | 23.4 | 11.9 | 0.00 % | 9.72 % | 3.44 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 28.0 Cr. | 19.1 | 19.5/8.35 | 36.3 | 6.64 | 0.00 % | 4.06 % | 3.33 % | 10.0 |
| Godavari Drugs Ltd | 86.2 Cr. | 114 | 155/87.0 | 12.9 | 55.4 | 0.00 % | 12.7 % | 15.5 % | 10.0 |
| Glenmark Life Sciences Ltd | 13,265 Cr. | 1,083 | 1,335/620 | 31.3 | 207 | 2.08 % | 28.1 % | 21.1 % | 2.00 |
| Gennex Laboratories Ltd | 434 Cr. | 19.1 | 29.0/13.2 | 25.1 | 7.68 | 0.00 % | 14.4 % | 10.4 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.61 Cr. | 15.7 | 28.5/13.1 | 152 | 13.4 | 0.00 % | 3.19 % | 0.84 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 319 Cr. | 678 | 1,054/650 | 18.0 | 278 | 0.10 % | 17.6 % | 15.0 % | 10.0 |
| Fervent Synergies Ltd | 50.8 Cr. | 17.0 | 27.8/14.6 | 11.8 | 0.00 % | 34.8 % | 34.9 % | 10.0 | |
| Fermenta Biotech Ltd | 983 Cr. | 334 | 355/145 | 120 | 98.6 | 0.37 % | 3.20 % | 5.59 % | 5.00 |
| Fabino Enterprises Ltd | 5.88 Cr. | 28.0 | 43.8/23.6 | 118 | 20.0 | 0.00 % | 1.68 % | 1.21 % | 10.0 |
| Evoq Remedies Ltd | 19.4 Cr. | 7.79 | 19.4/7.30 | 43.1 | 18.6 | 0.00 % | 1.91 % | 1.80 % | 10.0 |
| Everest Organics Ltd | 93.5 Cr. | 117 | 184/110 | 50.6 | 0.00 % | 6.03 % | 0.30 % | 10.0 | |
| Murae Organisor Ltd | 97.6 Cr. | 1.40 | 3.10/0.98 | 132 | 3.80 | 0.00 % | 0.79 % | 0.13 % | 2.00 |
| Dipna Pharmachem Ltd | 16.7 Cr. | 6.95 | 14.5/6.40 | 15.3 | 15.6 | 0.00 % | 7.05 % | 3.52 % | 10.0 |
| Decipher Labs Ltd | 15.6 Cr. | 15.5 | 25.8/14.4 | 18.8 | 21.3 | 0.00 % | 3.09 % | 6.75 % | 10.0 |
| Coral Laboratories Ltd | 303 Cr. | 848 | 999/345 | 13.0 | 570 | 0.24 % | 12.6 % | 9.58 % | 10.0 |
| Concord Drugs Ltd | 35.9 Cr. | 35.9 | 61.5/30.6 | 33.9 | 0.00 % | 4.50 % | 1.29 % | 10.0 | |
| Colinz Laboratories Ltd | 27.6 Cr. | 60.3 | 84.4/36.0 | 50.2 | 20.5 | 0.00 % | 7.70 % | 5.73 % | 10.0 |
| Cian Healthcare Ltd | 12.7 Cr. | 5.08 | 26.5/4.12 | 50.8 | 23.1 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 12.2 Cr. | 81.2 | 94.7/40.4 | 9.74 | 91.1 | 0.00 % | 13.3 % | 9.67 % | 10.0 |
| Checkpoint Trends Ltd | 7.53 Cr. | 13.8 | 17.4/4.09 | 0.93 | 0.00 % | 3.36 % | 5.77 % | 10.0 | |
| Chandra Bhagat Pharma Ltd | 52.1 Cr. | 69.0 | 160/63.0 | 33.0 | 39.4 | 0.00 % | 7.95 % | 5.42 % | 10.0 |
| Brawn Biotech Ltd | 6.66 Cr. | 22.2 | 27.8/14.6 | 14.1 | 0.00 % | 25.9 % | 21.8 % | 10.0 | |
| Bharat Immunological & Biological Corporation Ltd | 101 Cr. | 23.3 | 43.9/22.2 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Beryl Drugs Ltd | 17.0 Cr. | 33.4 | 46.0/19.5 | 49.9 | 18.3 | 0.00 % | 11.6 % | 8.95 % | 10.0 |
| BDH Industries Ltd | 177 Cr. | 307 | 408/175 | 18.2 | 110 | 1.46 % | 20.6 % | 16.9 % | 10.0 |
| Bacil Pharma Ltd | 27.7 Cr. | 47.1 | 50.0/4.68 | 71.1 | 2.87 | 0.00 % | 13.1 % | 13.8 % | 10.0 |
| Aurobindo Pharma Ltd | 73,184 Cr. | 1,249 | 1,593/958 | 20.1 | 527 | 0.36 % | 14.1 % | 11.5 % | 1.00 |
| Auro Laboratories Ltd | 124 Cr. | 199 | 307/112 | 20.1 | 69.6 | 0.00 % | 20.4 % | 20.5 % | 10.0 |
| Anuh Pharma Ltd | 967 Cr. | 193 | 265/140 | 16.4 | 60.5 | 1.30 % | 25.6 % | 19.5 % | 5.00 |
| ANG Lifesciences India Ltd | 58.8 Cr. | 45.0 | 86.1/44.4 | 56.2 | 0.00 % | 1.78 % | 8.72 % | 10.0 | |
| Ami Organics Ltd | 8,277 Cr. | 2,022 | 2,150/1,004 | 88.6 | 294 | 0.15 % | 16.0 % | 9.37 % | 10.0 |
| Amerise Biosciences Ltd | 6.81 Cr. | 1.03 | 1.20/0.55 | 0.80 | 0.00 % | 2.73 % | 2.75 % | 1.00 | |
| Ambalal Sarabhai Enterprises Ltd | 429 Cr. | 55.9 | 77.7/37.5 | 32.2 | 18.3 | 0.00 % | 7.08 % | 4.22 % | 10.0 |
| Adline Chem Lab Ltd | 14.6 Cr. | 25.0 | 29.0/11.9 | 2.70 | 0.00 % | % | % | 10.0 | |
| Achyut Healthcare Ltd | 109 Cr. | 65.0 | 82.5/40.2 | 166 | 18.5 | 0.00 % | 3.27 % | 2.52 % | 10.0 |
| Abbott India Ltd | 58,121 Cr. | 27,351 | 30,521/21,983 | 45.2 | 1,657 | 1.50 % | 46.0 % | 34.9 % | 10.0 |
| Aarti Pharmalabs Ltd | 5,957 Cr. | 657 | 722/381 | 26.1 | 205 | 0.46 % | 16.6 % | 13.1 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 155 Cr. | 55.6 | 75.8/37.0 | 22.5 | 46.6 | 0.00 % | 6.18 % | 3.81 % | 10.0 |
| Zota Health Care Ltd | 1,548 Cr. | 565 | 725/400 | 58.0 | 0.18 % | 7.32 % | 16.8 % | 10.0 | |
| Wockhardt Ltd | 17,953 Cr. | 1,170 | 1,335/318 | 221 | 0.00 % | 0.83 % | 12.1 % | 5.00 | |
| Wanbury Ltd | 751 Cr. | 229 | 291/91.0 | 27.2 | 11.8 | 0.00 % | 62.5 % | % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | 0.66 | 0.00 % | 11.0 % | 268 % | 2.00 | |
| Venus Remedies Ltd | 405 Cr. | 303 | 430/280 | 18.3 | 370 | 0.00 % | 8.57 % | 5.94 % | 10.0 |
| Unichem Laboratories Ltd | 6,293 Cr. | 894 | 950/401 | 126 | 341 | 0.00 % | 0.39 % | 1.17 % | 2.00 |
| TTK Healthcare Ltd | 2,006 Cr. | 1,420 | 1,923/1,232 | 31.0 | 735 | 0.70 % | 8.67 % | 6.43 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,04,995 Cr. | 3,102 | 3,591/2,025 | 60.3 | 222 | 0.90 % | 23.2 % | 24.2 % | 5.00 |
| Themis Medicare Ltd | 2,504 Cr. | 272 | 304/153 | 47.3 | 44.8 | 0.18 % | 13.5 % | 11.8 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,950 Cr. | 20.8 | 27.9/9.80 | 61.4 | 3.32 | 0.00 % | 10.2 % | 8.51 % | 1.00 |
| Suven Pharmaceuticals Ltd | 32,449 Cr. | 1,275 | 1,359/577 | 134 | 77.7 | 0.00 % | 18.8 % | 14.1 % | 1.00 |
| Suven Life Sciences Ltd | 2,613 Cr. | 120 | 169/74.5 | 8.84 | 0.00 % | 36.4 % | 36.3 % | 1.00 | |
| Sun Pharmaceuticals Industries Ltd | 4,24,250 Cr. | 1,768 | 1,960/1,180 | 37.9 | 288 | 0.76 % | 17.3 % | 16.7 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 3,294 Cr. | 758 | 851/292 | 302 | 0.00 % | 8.67 % | 33.5 % | 10.0 | |
| SMS Pharmaceuticals Ltd | 2,228 Cr. | 263 | 398/113 | 38.0 | 70.6 | 0.15 % | 11.4 % | 9.53 % | 1.00 |
| SMS Lifesciences India Ltd | 333 Cr. | 1,101 | 1,750/487 | 16.4 | 621 | 0.14 % | 6.89 % | 3.66 % | 10.0 |
| Shilpa Medicare Ltd | 8,540 Cr. | 873 | 960/313 | 149 | 238 | 0.00 % | 5.25 % | 1.71 % | 1.00 |
| Sequent Scientific Ltd | 4,809 Cr. | 193 | 241/91.8 | 226 | 27.2 | 0.00 % | 0.44 % | 3.09 % | 2.00 |
| Sanofi India Ltd | 14,231 Cr. | 6,179 | 7,600/4,606 | 33.8 | 298 | 2.70 % | 71.1 % | 51.5 % | 10.0 |
| RPG Life Sciences Ltd | 3,569 Cr. | 2,158 | 2,977/1,290 | 41.0 | 229 | 0.74 % | 34.6 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 8,546 Cr. | 5,148 | 5,836/4,637 | 37.7 | 324 | 1.17 % | 44.9 % | 33.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 265 Cr. | 75.2 | 87.5/31.9 | 19.0 | 0.00 % | 27.6 % | 16.8 % | 10.0 | |
| Pfizer Ltd | 23,821 Cr. | 5,207 | 6,453/3,947 | 38.9 | 820 | 0.67 % | 22.0 % | 16.1 % | 10.0 |
| Par Drugs & Chemicals Ltd | 334 Cr. | 271 | 325/190 | 18.3 | 78.6 | 0.00 % | 25.0 % | 18.5 % | 10.0 |
| Panacea Biotec Ltd | 2,191 Cr. | 358 | 399/112 | 136 | 0.00 % | 3.57 % | 3.17 % | 1.00 | |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Orchid Pharma Ltd | 7,306 Cr. | 1,440 | 1,592/519 | 61.4 | 241 | 0.00 % | 9.37 % | 9.94 % | 10.0 |
| Neuland Laboratories Ltd | 20,002 Cr. | 15,590 | 16,561/4,926 | 75.7 | 1,087 | 0.09 % | 33.3 % | 26.4 % | 10.0 |
| Nectar Lifescience Ltd | 791 Cr. | 35.3 | 56.5/25.0 | 73.7 | 48.1 | 0.00 % | 5.97 % | 0.46 % | 1.00 |
| Natco Pharma Ltd | 24,655 Cr. | 1,377 | 1,639/752 | 12.7 | 399 | 0.69 % | 30.1 % | 25.9 % | 2.00 |
| Morepen Laboratories Ltd | 4,143 Cr. | 75.6 | 101/38.6 | 31.6 | 20.3 | 0.00 % | 16.8 % | 12.0 % | 2.00 |
| Marksans Pharma Ltd | 13,971 Cr. | 308 | 329/126 | 40.4 | 50.3 | 0.19 % | 20.6 % | 16.5 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 167 Cr. | 106 | 145/85.2 | 17.7 | 93.2 | 0.00 % | 1.19 % | 6.12 % | 10.0 |
| Lyka Labs Ltd | 510 Cr. | 143 | 173/97.9 | 161 | 27.7 | 0.00 % | 3.95 % | 6.61 % | 10.0 |
| Lupin Ltd | 91,962 Cr. | 2,016 | 2,312/1,184 | 35.0 | 343 | 0.40 % | 15.7 % | 14.1 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,236 Cr. | 617 | 814/498 | 12.8 | 319 | 0.29 % | 22.3 % | 16.8 % | 10.0 |
| Laurus Labs Ltd | 26,203 Cr. | 486 | 518/359 | 111 | 79.2 | 0.16 % | 7.50 % | 5.43 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 924 Cr. | 890 | 961/340 | 26.8 | 234 | 0.00 % | 15.9 % | 13.7 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 184 Cr. | 85.1 | 122/60.0 | 60.4 | 0.00 % | 19.0 % | % | 10.0 | |
| Kopran Ltd | 1,089 Cr. | 226 | 370/198 | 20.6 | 103 | 1.33 % | 13.8 % | 11.0 % | 10.0 |
| Kilitch Drugs (India) Ltd | 537 Cr. | 334 | 470/298 | 38.2 | 118 | 0.00 % | 12.8 % | 7.83 % | 10.0 |
| Jubilant Pharmova Ltd | 18,618 Cr. | 1,169 | 1,310/409 | 65.4 | 373 | 0.43 % | 6.74 % | 0.76 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 26,123 Cr. | 1,682 | 2,030/1,371 | 42.8 | 207 | 0.73 % | 24.6 % | 20.0 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,413 Cr. | 534 | 635/270 | 52.8 | 74.4 | 0.94 % | 17.0 % | 13.0 % | 5.00 |
| Ipca Laboratories Ltd | 38,983 Cr. | 1,537 | 1,709/1,041 | 62.6 | 264 | 0.26 % | 12.8 % | 9.35 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,181 Cr. | 372 | 538/331 | 21.8 | 283 | 1.35 % | 12.3 % | 8.68 % | 10.0 |
| Indoco Remedies Ltd | 2,853 Cr. | 310 | 417/286 | 128 | 118 | 0.48 % | 10.4 % | 8.33 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 43,279 Cr. | 1,534 | 1,831/761 | 299 | 0.16 % | 12.3 % | 50.9 % | 1.00 | |
| Glaxosmithkline Pharmaceuticals Ltd | 41,626 Cr. | 2,457 | 3,088/1,565 | 51.9 | 98.7 | 1.30 % | 51.3 % | 37.3 % | 10.0 |
| Dr Reddys Laboratories Ltd | 1,02,354 Cr. | 1,227 | 1,421/1,074 | 19.2 | 369 | 0.65 % | 26.5 % | 21.4 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,332 Cr. | 213 | 283/133 | 366 | 0.00 % | 0.02 % | 2.64 % | 2.00 | |
| Cipla Ltd | 1,21,119 Cr. | 1,500 | 1,702/1,165 | 26.3 | 351 | 0.87 % | 22.8 % | 16.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,834 Cr. | 1,952 | 2,177/1,178 | 30.1 | 334 | 0.26 % | 26.5 % | 24.2 % | 2.00 |
| Brooks Laboratories Ltd | 357 Cr. | 136 | 186/72.5 | 22.6 | 0.00 % | 24.7 % | 28.1 % | 10.0 | |
| Bliss GVS Pharma Ltd | 1,243 Cr. | 118 | 150/92.2 | 14.1 | 96.0 | 0.42 % | 14.4 % | 10.2 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 102 Cr. | 62.6 | 92.0/42.6 | 192 | 11.3 | 0.00 % | 4.94 % | 4.00 % | 10.0 |
| Biocon Ltd | 40,316 Cr. | 336 | 396/231 | 27.9 | 175 | 0.15 % | 5.96 % | 5.25 % | 5.00 |
| Beta Drugs Ltd | 1,968 Cr. | 2,047 | 2,326/1,060 | 48.0 | 188 | 0.00 % | 32.8 % | 26.0 % | 10.0 |
| Bal Pharma Ltd | 192 Cr. | 121 | 158/89.0 | 25.2 | 43.2 | 1.00 % | 12.1 % | 11.1 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 189 Cr. | 80.0 | 113/73.2 | 246 | 35.0 | 0.00 % | 9.48 % | 9.44 % | 10.0 |
| Astrazeneca Pharma India Ltd | 16,932 Cr. | 6,773 | 8,140/4,050 | 132 | 272 | 0.35 % | 31.1 % | 22.9 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,027 Cr. | 701 | 863/556 | 42.6 | 103 | 0.66 % | 21.3 % | 15.5 % | 1.00 |
| Alpa Laboratories Ltd | 228 Cr. | 109 | 145/69.9 | 11.0 | 83.0 | 0.00 % | 13.7 % | 11.2 % | 10.0 |
| Alkem Laboratories Ltd | 66,059 Cr. | 5,525 | 6,440/4,381 | 30.4 | 961 | 0.72 % | 19.7 % | 19.6 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 20,207 Cr. | 1,028 | 1,304/710 | 31.8 | 249 | 1.07 % | 13.1 % | 13.3 % | 2.00 |
| Albert David Ltd | 754 Cr. | 1,320 | 1,754/911 | 11.0 | 724 | 0.87 % | 27.8 % | 21.7 % | 10.0 |
| Ajanta Pharma Ltd | 35,723 Cr. | 2,860 | 3,486/1,850 | 40.8 | 294 | 1.26 % | 31.6 % | 23.2 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 4,249 Cr. | 380 | 571/313 | 29.0 | 120 | 1.34 % | 15.2 % | 11.2 % | 2.00 |
| Aarti Drugs Limited | 4,315 Cr. | 469 | 635/430 | 34.5 | 126 | 0.21 % | 13.7 % | 12.4 % | 10.0 |
| Industry Average | 19,538.62 Cr | 1,195.66 | 54.76 | 184.88 | 0.32% | 16.40% | 16.92% | 6.61 |
